4//SEC Filing
SAENGER BRADLEY 4
Accession 0001839882-25-011958
CIK 0001430306other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 6:51 PM ET
Size
9.7 KB
Accession
0001839882-25-011958
Insider Transaction Report
Form 4
SAENGER BRADLEY
Chief Financial Officer
Transactions
- Award
Stock Option
2025-02-25+25,792→ 25,792 totalExercise: $8.05From: 2026-02-25Exp: 2035-02-25→ Common Stock (25,792 underlying) - Other
Common Stock, par value $0.001
2025-02-05−0.04→ 0 total - Award
Stock Option
2025-02-25+25,792→ 25,792 totalExercise: $10.06From: 2026-02-25Exp: 2035-02-25→ Common Stock (25,792 underlying)
Footnotes (3)
- [F1]Shares were surrendered without considerations following a reverse stock split of the Issuer's common stock.
- [F2]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F3]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.
Documents
Issuer
Tonix Pharmaceuticals Holding Corp.
CIK 0001430306
Entity typeother
Related Parties
1- filerCIK 0001668150
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 6:51 PM ET
- Size
- 9.7 KB